[go: up one dir, main page]

AU7264091A - Process for the preparation of castanospermine - Google Patents

Process for the preparation of castanospermine

Info

Publication number
AU7264091A
AU7264091A AU72640/91A AU7264091A AU7264091A AU 7264091 A AU7264091 A AU 7264091A AU 72640/91 A AU72640/91 A AU 72640/91A AU 7264091 A AU7264091 A AU 7264091A AU 7264091 A AU7264091 A AU 7264091A
Authority
AU
Australia
Prior art keywords
castanospermine
substituted
preparation
starting
hydroxypyrrolidinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU72640/91A
Other versions
AU630543B2 (en
Inventor
Paul T. Angell
Peter B. Anzeveno
Laura J. Creemer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of AU7264091A publication Critical patent/AU7264091A/en
Application granted granted Critical
Publication of AU630543B2 publication Critical patent/AU630543B2/en
Assigned to MERRELL PHARMACEUTICALS INC. reassignment MERRELL PHARMACEUTICALS INC. Request to Amend Deed and Register Assignors: MERRELL DOW PHARMACEUTICALS INC.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Castanospermine (I) is prepared by starting from 5-(t-BOC)amino-5-deoxy-1,2-O-isopropylidene- alpha -D-glucuronolactone. Two additional carbons are added to the starting material using ethyl acetate and a strong base and the resulting cyclic hemiketal is subjected to a series of reductions, with intervening removal of protecting groups, to give the castanospermine. A substituted hydroxypyrrolidinone and a substituted hydroxypyrrolidine serve as intermediates in the process. <CHEM> -
AU72640/91A 1990-03-12 1991-03-06 Process for the preparation of castanospermine Expired AU630543B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/492,507 US5066807A (en) 1990-03-12 1990-03-12 Process for the preparation of castanospermine
US492507 1990-03-12

Publications (2)

Publication Number Publication Date
AU7264091A true AU7264091A (en) 1991-09-12
AU630543B2 AU630543B2 (en) 1992-10-29

Family

ID=23956525

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72640/91A Expired AU630543B2 (en) 1990-03-12 1991-03-06 Process for the preparation of castanospermine

Country Status (15)

Country Link
US (1) US5066807A (en)
EP (1) EP0446832B1 (en)
JP (1) JP3019269B2 (en)
KR (1) KR0160136B1 (en)
AT (1) ATE139231T1 (en)
AU (1) AU630543B2 (en)
CA (1) CA2037608C (en)
DE (1) DE69120108T2 (en)
DK (1) DK0446832T3 (en)
ES (1) ES2090156T3 (en)
GR (1) GR3020707T3 (en)
HU (1) HU210048B (en)
IE (1) IE910803A1 (en)
IL (1) IL97487A (en)
ZA (1) ZA911742B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288875A (en) * 1991-08-14 1994-02-22 Cha Jin K Synthesis of (-)-swainsonine and intermediate compounds employed in such synthesis
CA2115260A1 (en) * 1991-08-09 1993-02-18 Klaes Golman Use of persistent free-radicals in magnetic resonance imaging
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
KR20070061879A (en) * 2004-10-06 2007-06-14 미게닉스 인코포레이티드 Combination anti-viral composition comprising castanospermine and method of use thereof
US10377818B2 (en) 2015-01-30 2019-08-13 The Board Of Trustees Of The Leland Stanford Junior University Method of treating glioma
KR101966101B1 (en) 2017-11-27 2019-04-05 주식회사 인트켐 Hybrid Admixture Composition for Self-Healing Properties and Cement Binder Composition Using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1315276C (en) * 1987-07-02 1993-03-30 Paul S. Liu Castanospermine esters and glycosides
US4970317A (en) * 1989-08-08 1990-11-13 Merrell Dow Pharmaceuticals Inc. Process for the preparation of castanospermine esters
US5227479A (en) * 1989-12-20 1993-07-13 Merrell Dow Pharmaceuticals Inc. Process for the preparation of nojirimycin and related compounds

Also Published As

Publication number Publication date
ATE139231T1 (en) 1996-06-15
IL97487A0 (en) 1992-06-21
HUT57208A (en) 1991-11-28
HU910790D0 (en) 1991-09-30
KR910016749A (en) 1991-11-05
KR0160136B1 (en) 1998-12-01
IE910803A1 (en) 1991-09-25
DK0446832T3 (en) 1996-07-01
AU630543B2 (en) 1992-10-29
JPH04217978A (en) 1992-08-07
IL97487A (en) 1995-05-26
CA2037608C (en) 2000-11-21
GR3020707T3 (en) 1996-11-30
CA2037608A1 (en) 1991-09-13
ES2090156T3 (en) 1996-10-16
EP0446832A2 (en) 1991-09-18
US5066807A (en) 1991-11-19
EP0446832A3 (en) 1992-03-25
DE69120108D1 (en) 1996-07-18
HU210048B (en) 1995-01-30
EP0446832B1 (en) 1996-06-12
DE69120108T2 (en) 1997-02-06
JP3019269B2 (en) 2000-03-13
ZA911742B (en) 1991-12-24

Similar Documents

Publication Publication Date Title
AU2355292A (en) Novel process for the preparation of 4-substituted-1, 4-dihydropydrines
EP0400472A3 (en) Process for preparing polyethylene glycol derivatives and modified protein.
AU6326890A (en) Improvements in or relating to organic compounds
AU4344889A (en) Process for the preparation of 7-substituted-hept-6-enoic and-heptanoic acids and derivatives
IE39904L (en) Benzodiazepines.
CA2037608A1 (en) Process for the preparation of castanospermine
EP0530369A4 (en) Crystal comprising indolinospirobenzothiopyran derivative and ring-opening isomer thereof
FI904164A0 (en) FOERBAETTRAT FOERFARANDE FOER FRAMSTAELLNING AV CYKLISKA AMINOSYRAFOERENINGAR.
AU2139792A (en) Method for production of 2-amino-6-halogenopurine and synthesis intermediate therefor
ES8802043A1 (en) Heterocyclic dissymmetric 1,4-dihydropyridine-3,5-dicarboxylic-acid esters, process for their preparation and their therapeutical use.
EP0466942A4 (en) Composition comprising epoxy compounds having hydroxyl group and process for producing the same
ES2058047T3 (en) RESOLUTION OF ARILALCANOIC ACID.
EP0477983A3 (en) Unsaturated polylactone acrylates and derivatives thereof
ATE127782T1 (en) PRODUCTION OF ALKANESULFONAMIDS.
JPS6490182A (en) Production of hydroxy-macrocyclic lactone
IE811421L (en) Dibenzindoles.
EP0367671A3 (en) Novel beta-d-phenylthioxylosides, their method of preparation and their use as pharmaceuticals
JPS5432480A (en) Novel preparation of piperidine derivatives
SE442873B (en) PROCEDURE FOR PREPARING A NEW ANTIBIOTICUM C-15003 WITH STATED FORM BY CULTIVATION OF NOCARDIA NO C-15003 (IFO 13726, FERM 3992, ATCC 31281)
WO1987007603A1 (en) beta-LACTAM COMPOUNDS AND PROCESS FOR THEIR PREPARATION
AU3146789A (en) Process for the preparation of a pyrrole derivative
JPS5459287A (en) Preparation of 2,2,6,6-tetramethylpiperidne derivative
GB1156853A (en) A process for the preparation of Thiazine Lactones and the Compounds so prepared
JPS51133271A (en) Process for preparing heterocyclic compounds
JPS52108961A (en) Coriolin derivatives and preparation thereof

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: MERRELL PHARMACEUTICALS INC.

Free format text: FORMER NAME WAS: MERRELL DOW PHARMACEUTICALS INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired